16.78
price down icon4.28%   -0.75
after-market 시간 외 거래: 16.79 0.010 +0.06%
loading
전일 마감가:
$17.53
열려 있는:
$17.45
하루 거래량:
19.85M
Relative Volume:
1.68
시가총액:
$19.24B
수익:
$16.54B
순이익/손실:
$-1.64B
주가수익비율:
-11.57
EPS:
-1.45
순현금흐름:
$749.00M
1주 성능:
-1.06%
1개월 성능:
+7.70%
6개월 성능:
+0.00%
1년 성능:
-0.71%
1일 변동 폭
Value
$16.70
$17.47
1주일 범위
Value
$16.70
$18.28
52주 변동 폭
Value
$12.46
$22.80

테바 ADR Stock (TEVA) Company Profile

Name
명칭
Teva Pharmaceutical Industries Ltd Adr
Name
전화
972 (3) 914-8213
Name
주소
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Name
직원
35,686
Name
트위터
@TevaUSA
Name
다음 수익 날짜
2025-01-29
Name
최신 SEC 제출 서류
Name
TEVA's Discussions on Twitter

TEVA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.78 19.45B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.35 50.14B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
168.63 72.38B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.79 4.22M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 45.51B 30.08B 710.16M 4.45B 0.2182

테바 ADR Stock (TEVA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-12 업그레이드 JP Morgan Neutral → Overweight
2024-07-10 업그레이드 Argus Hold → Buy
2024-03-08 업그레이드 JP Morgan Underweight → Neutral
2024-02-12 업그레이드 Piper Sandler Neutral → Overweight
2024-01-23 업그레이드 Jefferies Hold → Buy
2024-01-03 업그레이드 Piper Sandler Underweight → Neutral
2023-12-18 개시 HSBC Securities Buy
2023-11-27 업그레이드 UBS Neutral → Buy
2023-07-06 업그레이드 UBS Sell → Neutral
2023-05-25 개시 Morgan Stanley Equal-Weight
2023-05-18 업그레이드 Evercore ISI In-line → Outperform
2023-01-19 다운그레이드 Jefferies Buy → Hold
2022-11-14 다운그레이드 JP Morgan Neutral → Underweight
2022-11-04 다운그레이드 UBS Neutral → Sell
2022-10-21 재개 Jefferies Buy
2022-08-05 업그레이드 BofA Securities Neutral → Buy
2022-06-14 재개 UBS Neutral
2022-05-17 업그레이드 BofA Securities Underperform → Neutral
2022-05-04 다운그레이드 Piper Sandler Neutral → Underweight
2022-04-05 업그레이드 Barclays Equal Weight → Overweight
2022-03-25 업그레이드 Bernstein Mkt Perform → Outperform
2022-01-27 다운그레이드 Argus Buy → Hold
2021-10-28 다운그레이드 Raymond James Outperform → Mkt Perform
2021-05-04 다운그레이드 UBS Buy → Neutral
2021-04-07 재개 RBC Capital Mkts Sector Perform
2020-11-25 개시 Oppenheimer Perform
2020-08-06 업그레이드 Barclays Underweight → Equal Weight
2020-07-27 재개 Goldman Neutral
2020-06-01 업그레이드 SunTrust Hold → Buy
2020-04-24 재개 Citigroup Neutral
2020-04-06 업그레이드 UBS Neutral → Buy
2020-02-24 다운그레이드 Edward Jones Hold → Sell
2019-11-12 업그레이드 JP Morgan Underweight → Neutral
2019-10-17 업그레이드 Gabelli & Co Hold → Buy
2019-08-07 다운그레이드 Evercore ISI Outperform → In-line
2019-07-19 개시 Wolfe Research Peer Perform
2019-07-15 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2019-07-10 재개 Credit Suisse Neutral
2019-07-05 업그레이드 Argus Hold → Buy
2019-06-11 개시 Barclays Underweight
2019-06-03 업그레이드 Oppenheimer Perform → Outperform
2019-05-30 다운그레이드 BofA/Merrill Buy → Underperform
2019-05-28 다운그레이드 UBS Buy → Neutral
2019-03-20 개시 SunTrust Hold
2019-03-07 재개 UBS Buy
모두보기

테바 ADR 주식(TEVA)의 최신 뉴스

pulisher
09:00 AM

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to Date - GlobeNewswire Inc.

09:00 AM
pulisher
May 29, 2025

Teva: New Long-Term Targets and Sold Pipeline Reaffirm Our Favorable Outlook; Shares Undervalued - Morningstar

May 29, 2025
pulisher
May 28, 2025

TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate - Yahoo Finance

May 28, 2025
pulisher
May 20, 2025

Restart of Student Loan Repayments Could Squeeze Consumer Spending and Slow Economic Growth - iHeart

May 20, 2025
pulisher
May 19, 2025

Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - GlobeNewswire Inc.

May 19, 2025
pulisher
May 12, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

May 12, 2025
pulisher
May 07, 2025

Teva Earnings: Innovation Propels Sales and Generics Show Stability in Solid Start to the Year - Morningstar

May 07, 2025
pulisher
May 05, 2025

Teva and Alvotech stocks jump on FDA approval of SELARSDI - Investing.com

May 05, 2025
pulisher
May 05, 2025

Teva and Alvotech stocks jump on FDA approval of SELARSDI By Investing.com - Investing.com Canada

May 05, 2025
pulisher
Apr 30, 2025

There Are Mixed Signals on the Chart for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Digi Power X Inc (DGXX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com

Apr 30, 2025
pulisher
Apr 29, 2025

Market Analysts see Norwegian Cruise Line Holdings Ltd [NCLH] gaining to $21. Time to buy? - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

PG&E Corp [PCG] Revenue clocked in at $24.54 billion, down -14.37% YTD: What’s Next? - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Greenwave Technology Solutions Inc [GWAV] Is Currently 12.13 above its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Performance and Fundamentals Dashboard tells a completely different story – Sete News - Sete News

Apr 29, 2025
pulisher
Apr 29, 2025

Raymond James slashes price target on Adma Biologics Inc [ADMA] – find out why. - dbtnews.com

Apr 29, 2025
pulisher
Apr 28, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: A Year of Highs and Lows - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

Company’s Banking Stock: Dissecting a 37.52% Quarterly Revenue Decline Amid Growth - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

NEOV’s Market Whiplash: -48.46% YTD Decline, 15.24% Rise in 30 Days - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

Adagio Medical Holdings Inc (ADGM) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 28, 2025
pulisher
Apr 25, 2025

A company insider recently sold 70,961 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale? - knoxdaily.com

Apr 25, 2025
pulisher
Apr 24, 2025

Introducing Our Rant Against Teva- Pharmaceutical Industries Ltd. ADR - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

OS overperforms with a 2.12 increase in share price - uspostnews.com

Apr 24, 2025
pulisher
Apr 23, 2025

For Kopin Corp [KOPN], Analyst sees a rise to $2. What next? - dbtnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Market Analysts see Geron Corp [GERN] falling to $2. Time to buy? - dbtnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com

Apr 23, 2025
pulisher
Apr 22, 2025

The growth track for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has changed recently - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

Rezolute Inc: Weathering Stock Market Storms with 190.08M Market Cap - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Ready to Jump After Recent Trade: NIO Inc ADR (NIO) - Sete News

Apr 22, 2025
pulisher
Apr 21, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

ORCL’s Stock Journey: What Investors Need to Know About Oracle Corp’s Performance - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

TGB Stock Update: Taseko Mines Ltd’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

Lexicon Pharmaceuticals Inc (LXRX) Stock: A Year of Market Fluctuations - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

HESM’s latest rating updates from top analysts. - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

Analysts review Teva- Pharmaceutical Industries Ltd. ADR’s rating - knoxdaily.com

Apr 21, 2025
pulisher
Apr 16, 2025

Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com

Apr 16, 2025
pulisher
Apr 02, 2025

Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

What technical indicators reveal about MYGN stock - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

VF Corp (VFC) is a good investment, but the stock may be overvalued - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

Investing in Calumet Inc (CLMT) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

Wabash National Corp (WNC) stock on the rise: An overview - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

The Gryphon Digital Mining Inc (GRYP) had a good session last reading, didn’t it? - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar

Apr 02, 2025
pulisher
Mar 27, 2025

What will the future hold for CarGurus Inc (NASDAQ:CARG) stock? - US Post News

Mar 27, 2025
pulisher
Mar 25, 2025

TEVA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Mar 25, 2025
pulisher
Mar 18, 2025

Teva Pharmaceutical Stock Scores RS Rating Upgrade - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

IBD Rating Upgrades: Teva Pharmaceutical ADR Flashes Improved Relative Price Strength - Investor's Business Daily

Mar 18, 2025

테바 ADR (TEVA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_specialty_generic TAK
$15.03
price up icon 1.55%
$318.85
price down icon 0.47%
drug_manufacturers_specialty_generic RDY
$14.72
price down icon 0.20%
$123.02
price down icon 0.52%
drug_manufacturers_specialty_generic HCM
$13.89
price up icon 0.22%
자본화:     |  볼륨(24시간):